Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+26.1%
5Y CAGR+34.9%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+26.1%/yr
vs +46.0%/yr prior
5Y CAGR
+34.9%/yr
Recent deceleration
Acceleration
-19.9pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.5x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $196.27M | +16.8% |
| 2024 | $168.01M | +29.8% |
| 2023 | $129.43M | +32.1% |
| 2022 | $97.95M | +14.0% |
| 2021 | $85.95M | +95.7% |
| 2020 | $43.92M | +30.1% |
| 2019 | $33.75M | +56.5% |
| 2018 | $21.56M | +138.4% |
| 2017 | $9.04M | +37.8% |
| 2016 | $6.56M | - |